Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Roger Pomerantz

Affiliations

  • Chief Executive Officer at Contrafect Corp (CFRX), 2020-02-24
  • Director at Intec Pharma Ltd. (NTEC), 2019-07-02
  • Director at Seres Therapeutics Inc. (MCRB), 2019-06-14
  • Director at Rubius Therapeutics Inc. (RUBY), 2018-07-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RUBY $23.00 100 Director 100 2018-07-20 Filing
CFRX $1.24 800 Director 800 2017-07-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MCRB $9.00 1,810 Officer, Director 213,976 2018-09-07 Filing
MCRB $9.04 3,013 Officer, Director 215,786 2018-09-06 Filing
MCRB $9.12 9,505 Officer, Director 218,799 2018-09-05 Filing
MCRB $9.01 1,010 Officer, Director 228,304 2018-07-11 Filing
MCRB $9.05 5,989 Officer, Director 228,304 2018-07-10 Filing